{ "items": [ "\n\n
\n \n Other\n \n
\n \n\n \n \n \nAznar MC. et al, (2016), Int J Radiat Oncol Biol Phys, 96, E30 - E31
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMcGale P. et al, (2016), J Clin Oncol, 34, 3355 - 3357
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLorenzen EL. et al, (2016), Radiother Oncol, 119, 71 - 76
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHenson KE. et al, (2016), J Clin Oncol, 34, 803 - 809
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor CW. et al, (2015), Int J Radiat Oncol Biol Phys, 93, 845 - 853
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor CW. and Kirby AM., (2015), Clin Oncol (R Coll Radiol), 27, 621 - 629
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2015), Lancet, 386, 1353 - 1361
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nVan den Heuvel F. et al, (2015), Med Phys, 42
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDuane FK. et al, (2015), RADIOTHERAPY AND ONCOLOGY, 115, S338 - S339
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative Group None., (2014), The Lancet, 384, 1846 - 1847
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEBCTCG (Early Breast Cancer Trialists' Collaborative Group) None. et al, (2014), Lancet, 383, 2127 - 2135
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor C. and Darby SC., (2014), JAMA Intern Med, 174, 160 - 161
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor CW. et al, (2013), International Journal of Radiation Oncology Biology Physics, 87
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLorenzen EL. et al, (2013), Radiother Oncol, 108, 254 - 258
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHenson KE. et al, (2013), Br J Cancer, 108, 179 - 182
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 1707 - 1716
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 771 - 784
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor CW. et al, (2011), Radiotherapy and Oncology, 100, 176 - 183
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTaylor CW. et al, (2011), Radiother Oncol, 100, 176 - 183
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMcGale P. et al, (2011), Radiotherapy and Oncology, 100, 167 - 175
\n \n \n \n\n
\n \n \n \n